Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of AZD6244 (NSC# 748727) in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum

NCT00551070 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00551070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of AZD6244 (NSC# 748727) in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
December 17, 2007
Completion date
November 13, 2020
Enrollment
52 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

borderline ovarian serous tumor, low grade ovarian serous adenocarcinoma, micropapillary serous carcinoma, primary peritoneal carcinoma, primary peritoneal low grade serous adenocarcinoma, recurrent borderline ovarian surface epithelial-stromal tumor